Page last updated: 2024-08-23

staurosporine and Leukemia, Biphenotypic, Acute

staurosporine has been researched along with Leukemia, Biphenotypic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adam, JP; Bambace, N; Bouchard, P; Otis, AS; Pépin, MA; Soulières, D; Tremblay, Z; Wong, A	1

Other Studies

1 other study(ies) available for staurosporine and Leukemia, Biphenotypic, Acute

Article	Year
Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series. European journal of haematology, 2022, Volume: 108, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Lineage; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Biphenotypic, Acute; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phenotype; Protein Kinase Inhibitors; Staurosporine; Treatment Outcome	2022

Article

Year

Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.

European journal of haematology, 2022, Volume: 108, Issue:2

Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Lineage; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Biphenotypic, Acute; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Phenotype; Protein Kinase Inhibitors; Staurosporine; Treatment Outcome

2022